Enhancing access control with hybrid finger vein and fingerprint technology
Providing highly secure access control solutions that can be used by everyone – to protect premises or the restricted areas of a building – is an increasing issue for many organizations. To meet that need, IDEMIA has developed the first access control terminal to combine finger vein and fingerprint biometrics in a single unit: MorphoAccess VP.
This advanced hybrid technology provides unrivalled accuracy and enhanced resistance to spoofing. The False Rejection Rate (FRR) of MorphoAccess VP is 10 times lower than the best rate obtained with finger vein or fingerprint data when processed alone. In addition, this multimodal reader is universal and easy-to-adopt: it is well suited to individuals who may experience difficulties with single-mode devices while offering the same ease of use as for fingerprints alone.
MorphoAccess VP delivers both one-to-many identification (up to 1:10,000) and one-to-one authentication (reading MIFARE/DESFire contactless cards).
The hybrid terminal ensures reliable identification even for individuals who have difficulty with single-mode systems. By combining two complementary biometrics, it ensures highly efficient matching for genuine individuals and sharply reduces the risk of accepting impostors. It gives an efficient response to both convenience and security concerns for any application.
The technology combines the protection mechanisms intrinsic to each biometrics – e.g. the vein network lying under the skin is impossible to acquire without user’s consent – and makes the most of the new characteristics resulting from the fusion.
MorphoAccess VP can secure multiple use case scenarios, whether indoors or outdoors. Its standard 5,000 user storage capacity can be increased to 10,000 users to adapt to the size of a growing company. For cases requiring the use of badges, it natively supports MIFARE/DESFire contactless smartcards in addition to biometrics.
Looking for additional information? Our experts are available for you.